Oppenheimer & Co’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q2
Sell
-3,812
Closed -$240K 1329
2020
Q1
$240K Sell
3,812
-4,788
-56% -$301K 0.01% 979
2019
Q4
$1.07M Sell
8,600
-314
-4% -$38.9K 0.03% 603
2019
Q3
$592K Sell
8,914
-701
-7% -$46.6K 0.02% 733
2019
Q2
$766K Buy
9,615
+4,712
+96% +$375K 0.02% 677
2019
Q1
$548K Buy
4,903
+2,522
+106% +$282K 0.01% 783
2018
Q4
$240K Sell
2,381
-425
-15% -$42.8K 0.01% 1040
2018
Q3
$355K Sell
2,806
-3,661
-57% -$463K 0.01% 1001
2018
Q2
$542K Sell
6,467
-13
-0.2% -$1.09K 0.01% 830
2018
Q1
$399K Buy
6,480
+1,585
+32% +$97.6K 0.01% 939
2017
Q4
$286K Buy
4,895
+110
+2% +$6.43K 0.01% 1073
2017
Q3
$278K Buy
4,785
+2,833
+145% +$165K 0.01% 1062
2017
Q2
$237K Sell
1,952
-200
-9% -$24.3K 0.01% 1115
2017
Q1
$244K Buy
2,152
+178
+9% +$20.2K 0.01% 1084
2016
Q4
$214K Sell
1,974
-1,258
-39% -$136K 0.01% 1131
2016
Q3
$532K Sell
3,232
-548
-14% -$90.2K 0.02% 790
2016
Q2
$540K Sell
3,780
-294
-7% -$42K 0.02% 761
2016
Q1
$524K Sell
4,074
-997
-20% -$128K 0.02% 736
2015
Q4
$757K Sell
5,071
-1,316
-21% -$196K 0.02% 643
2015
Q3
$1.06M Buy
6,387
+1,575
+33% +$261K 0.03% 563
2015
Q2
$1.16M Buy
4,812
+698
+17% +$169K 0.03% 577
2015
Q1
$1.16M Sell
4,114
-2,705
-40% -$763K 0.03% 589
2014
Q4
$1.06M Buy
6,819
+3,044
+81% +$475K 0.03% 583
2014
Q3
$893K Buy
3,775
+1,739
+85% +$411K 0.03% 636
2014
Q2
$482K Sell
2,036
-15
-0.7% -$3.55K 0.01% 866
2014
Q1
$677K Buy
+2,051
New +$677K 0.02% 730